Small cap infant formula exporters milk Bellamy’s profit upgrade

Pic: Rommel Gonzalez / EyeEm / EyeEm via Getty Images
Small cap infant formula exporters gained on Tuesday after big brother Bellamy’s upgraded its revenue and profit guidance.
The $1.5 billion Bellamy’s upgraded expected revenue growth to between 30 and 35 per cent, up from 15 to 20 per cent.
The news pushed up shares (ASX:BAL) by 25 per cent to near 52-week highs.
Small cap infant formula exporters bathed in the after-glow.
Goat milk favourite Bubs (ASX:BUB) gained 5.5 per cent and Wattle Health (ASX:WHA) jumped 4.4 per cent.

Bioxyne’s ‘milk formula for the whole family’ also enjoyed a boost — its shares (ASX:BXN) trading up 3 per cent. Bioxyne also launch three new supplement products today.
Major player A2 Milk also got a look-in. It’s shares (ASX:A2M) climbed 5.7 per cent in afternoon trade.
Demand continues to grow in China and other Asian countries for Australia’s clean-and-green baby food products amid the recall of 12 million formula tins in a salmonella scare by French dairy company Lactalis last month.
The sector continues to expand. China-focused JAT Energy (ASX:JAT) already had exposure through its Cobbity Country subsidiary and bought into Golden Koala milk formula late last year.
Its shares have been suspended since mid-December and last closed at 70c.
Daigou retailer AuMake (ASX:AU8) told shareholder late last year it was in active discussions for its own branded products in the lucrative market.
UNLOCK INSIGHTS
Discover the untold stories of emerging ASX stocks.
Daily news and expert analysis, it's free to subscribe.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.